Navigation Links
Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Date:9/5/2007

CEOs, Venture Capitalists, Medical and Media Leaders Speakers and Panels;

Live Surgeries and 'Top 10' Innovations List to be Featured

CLEVELAND, Sept. 5 /PRNewswire/ -- Cleveland Clinic will host its annual Medical Innovation Summit, an international gathering of health care, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.

The 2007 Medical Innovation Summit will feature:

-- Nationally Recognized Speakers and Panelists: Sidney Taurel, Eli

Lilly; George Buckley, 3M; Bill Hawkins, Medtronic; Stephen Hemsley,

UnitedHealth Group; Tony Zook, AstraZeneca; and many other CEOs, top

venture investors, medical leaders and network correspondents will

explore top technology issues in cardiovascular medicine including

drug-eluting stents, stem cells, personalized care, wellness,

implantable devices, and treating arrhythmias of the heart. A complete

list of speakers is available online at

http://www.clevelandclinic.org/innovations/summit/.

-- "Top 10" Health Care Innovations: Cleveland Clinic clinicians and

researchers will announce and discuss their second annual selection of

the "Top 10" medical innovations they expect to have a significant

impact in 2008.

-- Live Surgeries: Two live, interactive surgeries will illustrate state

of the art treatments for cardiovascular disease. Surgeries will be

broadcast in the Bank of America Conference Center of the

InterContinental Hotel Cleveland each morning at 7:30 a.m.

This marks the fifth year Cleveland Clinic has hosted this international gathering of industry decision-makers to dissect advances revolutionizing health care and accelerate the application of life-saving cardiovascular technologies. The 2007 Medical Innovation Summit will draw 900 industry executives, entrepreneurs, venture capitalists and clinicians. Also featured will be the Cleveland Clinic's annual selection of the "Top 10" health care innovations, live, interactive surgeries and in-depth debates on industry challenges.

For more information on the Medical Innovation Summit, including the agenda, please visit http://www.clevelandclinic.org/innovations/summit/.

CCF Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CCF Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin- off companies, licensees and equity partnerships.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2006, there were 3.1 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were more than 53,000 hospital admissions to Cleveland Clinic in 2006. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
2. High iron levels may cause Cardiovascular Disease in women
3. Air Pollution said To Increase Risk of Cardiovascular Disease
4. Link Between Alcohol Consumption And Cardiovascular Disease
5. Beer Found To Be Effective In Fighting Cardiovascular Disease
6. New Guidelines Found To Benefit Cardiovascular Treatment
7. Women With A High-Risk Of Cardiovascular Disease Under treated
8. People who fight wars may be at high risk of cardiovascular disease
9. Low glycemic diet effective for reducing cardiovascular risk
10. Air pollution to affect diabetes patients’ cardiovascular risks
11. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: